TL;DR: TareBio is a Y Combinator Summer 2026 startup Vaccines for any cancer or infection in weeks, currently active with a team of 1.
Vaccines for any cancer or infection in weeks
Last verified:
Our platform develops personalized or population-level vaccines for any disease in weeks by changing only one input: the immune imprint. Instead of trying to predict which antigens might work, we read out immune cells already fighting the disease in the body and reverse-engineer antigens that activate them. We've already run our platform end-to-end and created a vaccine that cured cancer in mice.
Built by LemStudio
Yes. TareBio was funded by Y Combinator in the Summer 2026 batch. Vaccines for any cancer or infection in weeks
Our platform develops personalized or population-level vaccines for any disease in weeks by changing only one input: the immune imprint. Instead of trying to predict which antigens might work, we read out immune cells already fighting the disease in the body and reverse-engineer antigens that activate them. We've alre…
TareBio was part of Y Combinator's Summer 2026 batch.
TareBio has a team of 1 people according to Y Combinator's directory.
TareBio is currently listed as Active with a team of 1 in Y Combinator's directory.
Loading interactive view…